by Allison Inserro, AJMC Could artificial intelligence (AI) be used to identify patients with early-stage pancreatic cancer close to 2 years before the disease becomes apparent, and thus harder to treat? A presentation at the ESMO World Congress on Gastrointestinal...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkTerms of Use
